ES330013A1 - Un procedimiento para componer una preparacion farmaceutica. - Google Patents

Un procedimiento para componer una preparacion farmaceutica.

Info

Publication number
ES330013A1
ES330013A1 ES0330013A ES330013A ES330013A1 ES 330013 A1 ES330013 A1 ES 330013A1 ES 0330013 A ES0330013 A ES 0330013A ES 330013 A ES330013 A ES 330013A ES 330013 A1 ES330013 A1 ES 330013A1
Authority
ES
Spain
Prior art keywords
weight
adhesive composition
adhesive
coating
core material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0330013A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES330013A1 publication Critical patent/ES330013A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES0330013A 1965-08-09 1966-08-08 Un procedimiento para componer una preparacion farmaceutica. Expired ES330013A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US478437A US3365365A (en) 1965-08-09 1965-08-09 Repeat action pharmaceutical compositions in the form of discrete beadlets

Publications (1)

Publication Number Publication Date
ES330013A1 true ES330013A1 (es) 1967-06-16

Family

ID=23899930

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0330013A Expired ES330013A1 (es) 1965-08-09 1966-08-08 Un procedimiento para componer una preparacion farmaceutica.

Country Status (5)

Country Link
US (1) US3365365A (US07981874-20110719-C00313.png)
BE (1) BE685228A (US07981874-20110719-C00313.png)
BR (1) BR6681937D0 (US07981874-20110719-C00313.png)
ES (1) ES330013A1 (US07981874-20110719-C00313.png)
NL (1) NL6611190A (US07981874-20110719-C00313.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament
US5510115A (en) * 1987-11-16 1996-04-23 Baxter Travenol Laboratories, Inc. Method and composition for administration of beneficial agent by controlled dissolution
DE3877747T2 (de) * 1987-11-16 1993-05-13 Baxter Int Glasartige matrize zur verabreichung von heilmitteln.
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
CN102488652B (zh) 2006-03-16 2014-06-18 特瑞斯制药股份有限公司 含有药物-离子交换树脂复合物的经修饰释放的制剂
US8846100B2 (en) 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
WO2013003622A1 (en) 2011-06-28 2013-01-03 Neos Therapeutics, Lp Dosage forms for oral administration and methods of treatment using the same
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
IT201700048797A1 (it) * 2017-05-05 2018-11-05 Neilos S R L Sistema di rilascio controllato di ingredienti attivi a base di materiali polimerici e suo impiego in campo nutraceutico.
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043747A (en) * 1958-10-22 1962-07-10 Upjohn Co Tablets coated with carboxymethylcellulose shellac composition

Also Published As

Publication number Publication date
BE685228A (US07981874-20110719-C00313.png) 1967-02-08
US3365365A (en) 1968-01-23
BR6681937D0 (pt) 1973-10-25
NL6611190A (US07981874-20110719-C00313.png) 1967-02-10

Similar Documents

Publication Publication Date Title
ES330013A1 (es) Un procedimiento para componer una preparacion farmaceutica.
AT327390B (de) Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen
FI48318C (fi) Menetelmä terapeuttisesti aktiivista ainetta ja/tai bariumsulfaattia s isältävän kapselin tai päällystetyn, kokoonpuristetun tabletin valmist amiseksi lääkkeiden suun kautta tapahtuvaa antamista varten.
ATE128863T1 (de) Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
FI885460A (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
ES388698A1 (es) Procedimiento para la preparacion de pequenas bolitas medi-camentosas para administracion oral con un revestimiento re-tardador de la liberacion de sustancia activa.
SE402709B (sv) Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav
DE3780056D1 (de) Verfahren zur herstellung von arzneimittelformulierungen mit gesteuerter und verlaengerter wirkung in einzeldosisform mit einheitlichen und vergleichbaren bioverfuegbarkeitscharakteristika.
IL41784A0 (en) Novel optically active derivatives of 1-phenyl-2-aminoethanol,their preparation and pharmaceutical compositions containing them
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
FR2328466A1 (fr) Nouvelles 4-aminopyrazoles substituees, procede pour leur preparation et medicaments contenant ces composes
ATE77052T1 (de) Verfahren zur herstellung von etofibrat oder aehnliche verbindungen enthaltende mikrogranula mit verzoegerter freisetzung sowie die auf diese weise erhaltenen produkte.
GB1385285A (en) Pharmaceutical capsule wall materials
US2963402A (en) Sustained release medicament
DE2903778C2 (de) Verwendung von Hydroxypropylmethylcellulose zum Überziehen von den pharmazeutischen Wirkstoff in der Hülle enthaltenden Weichgelatine-Buccalkapseln
GB800973A (en) Improvements in or relating to pills or tablets
GB630439A (en) Improvements in or relating to pharmaceutical preparations
JPS5225015A (en) Process for preparing fine granular drugs
US2333283A (en) Administration capsule
GB764342A (en) Improvements in or relating to coated water soluble tablets
IL35841A (en) Pharmaceutical compositions containing quaternary n-isopropyl noratropinium methylate salts,and inhalers for their administration
ZA707072B (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
BE804161A (fr) Procede de preparation de 3,4-dihydropyridones et medicament contenant ces composes
ATA529576A (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
GB1243454A (en) Pharmaceutical compositions and their preparation